Literature DB >> 29377153

Clinical trials for myasthenia gravis: a historical perspective.

Henry J Kaminski1, Eman Alnosair1, Rami M Algahtani1.   

Abstract

Symposia dedicated to myasthenia gravis and related disorders date back to 1947 and serve as markers of the progress for the field. We provide a brief historical review of therapy development through the lens of the publications that arose from the close to quinquennial meetings that have been supported nearly since their inception by the Myasthenia Gravis Foundation of America and the New York Academy of Sciences. One can appreciate great advances, false starts, and dead ends that are found in all fields of medicine. We tally up the score card for MG and find points scored, but the win is not yet close.
© 2018 New York Academy of Sciences.

Entities:  

Keywords:  clinical trials; myasthenia gravis; mycophenolate; prednisone; tacrolimus

Mesh:

Substances:

Year:  2018        PMID: 29377153     DOI: 10.1111/nyas.13545

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

Review 1.  History of Myasthenia Gravis Revisited.

Authors:  Feza Deymeer
Journal:  Noro Psikiyatr Ars       Date:  2020-11-07       Impact factor: 1.339

Review 2.  Advances in autoimmune myasthenia gravis management.

Authors:  Shuhui Wang; Iva Breskovska; Shreya Gandhy; Anna Rostedt Punga; Jeffery T Guptill; Henry J Kaminski
Journal:  Expert Rev Neurother       Date:  2018-07-04       Impact factor: 4.618

Review 3.  Corticosteroid Treatment-Resistance in Myasthenia Gravis.

Authors:  Henry J Kaminski; Jordan Denk
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086

Review 4.  Monoclonal Antibody-Based Therapies for Myasthenia Gravis.

Authors:  Sawsan Alabbad; Mohanad AlGaeed; Patricia Sikorski; Henry J Kaminski
Journal:  BioDrugs       Date:  2020-10       Impact factor: 5.807

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.